NCT05257993 2026-04-13Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic CancerOnconic Therapeutics Inc.Phase 1/2 Recruiting71 enrolled